Navigation Links
Breast Cancer Drug Not Tied to Cognitive Decline: Study
Date:9/2/2008

Researchers say finding is 'good news' for postmenopausal women taking anastrozole

TUESDAY, Sept. 2 (HealthDay News) -- Contrary to previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found.

Anastrozole has been shown to be superior to tamoxifen in preventing breast cancer recurrence in postmenopausal women. But some "cross-sectional" studies have suggested that endocrine therapies such as anastrozole are associated with poorer performance on verbal memory and processing tasks.

For the new study, published in the October edition of The Lancet Oncology, researchers randomly assigned postmenopausal women to receive anastrozole or a placebo daily for five years.

Before the study began, and for six months and 24 months after starting treatment, a subset of 227 of the women underwent tests to measure their cognitive performance, including auditory verbal tasks, logical memory tasks, spatial span tests, and verbal fluency assessments.

There was no difference between the anastrozole or placebo groups at six months or 24 months in changes in attention or memory, or in the number of women who experienced cognitive decline in three or more cognitive tasks.

The only difference between the groups was that at the 24-month time point, significantly more women in the anastrozole group reported experiencing hot flushes.

The authors of the study pointed out that more research is needed to determine the longer-term effects of anastrozole, but said their findings were good news for women who take the medication.

"These findings should be reassuring in the short term for postmenopausal women being treated with anastrozole, their clinicians and carers," they wrote.

This study was part of the International Breast Intervention Study.

More information

The U.S. National Cancer Institute has more about anastrozole.



-- Krisha McCoy



SOURCE: The Lancet Oncology, news release, Sept. 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Hospitals provide formula sample packs while medical organizations encourage breastfeeding
2. Komen Travels to Republican Convention to Raise Awareness of Breast Cancer Issues
3. Superbug breast infections controllable in nursing mothers, UT Southwestern researchers find
4. Komen Travels to Democratic Convention in Denver to Raise Awareness of Breast Cancer Issues
5. Taking Codeine While Breast-Feeding May Harm Infant
6. Breastfeeding, other factors may affect risk of breast cancer type
7. Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry
8. Risk of Breast Cancer Relapse Can Linger
9. Risk assessment plays key role in long-term treatment of breast cancer
10. MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research
11. Breast-Feeding: The Stress Buster That Lasts for Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... 2016 , ... CURE Media Group , the nation’s ... today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center in ... Oncology Nursing , which honors nurses who have dedicated their careers to helping ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... to promote their animal line of probiotics, Petbiotics ™, as they fondly ... turnout of animal rescue groups networking for their non-profit organizations. Animal rescues across ...
(Date:4/29/2016)... ... 29, 2016 , ... Coalition Duchenne, a Newport Beach, California ... Duchenne research, participated in the April 25 U.S. Food and Drug Administration advisory ... The meeting at the Marriott Conference Center in Hyattsville, Maryland was attended by ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Calif. , April 28, 2016  Marking ... widely accessible breast and ovarian cancer risk test, ... panel analyzing 30 genes that highly impact the ... women. Available today, the Color Test analyzes hereditary ... prostate, stomach, and uterine cancers. The Color Test ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
Breaking Medicine Technology: